This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Truth About Market Timing - September 29, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Reasons Why Carlisle (CSL) Stock Should Be Avoided for Now
by Zacks Equity Research
End-market weakness, especially in commercial aerospace and automotive, due to the pandemic is concerning for Carlisle (CSL). It expects Q3 revenues for CIT, CBF and CFT segments to fall.
3M (MMM) Sales Rise Y/Y in August, Q3 Projections Impressive
by Zacks Equity Research
3M's (MMM) sales performance in August is driven by acquisitions/divestitures impact and forex gains, partially offset by the adverse impacts of lower business days. Q3 outlook for sales is promising.
The Keys to Successfully Timing the Markets - September 03, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Why Is Carlisle (CSL) Up 2.7% Since Last Earnings Report?
by Zacks Equity Research
Carlisle (CSL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3M (MMM) Sales Rise Y/Y in July, Quarterly Dividend Approved
by Zacks Equity Research
3M's (MMM) sales performance in July is driven by strengthening product demand despite the prevailing pandemic difficulties. Also, it receives approval for the quarterly dividend payment.
Griffon Prices 8M Underwritten Public Common Share Offering
by Zacks Equity Research
Griffon (GFF) prices 8-million common share offering. Proceeds raised will be used for debt reduction and other corporate purposes.
Yes, You Can Time the Market. Find out How - August 12, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Griffon (GFF) to Offer 8M Common Shares, To Pay Down Debts
by Zacks Equity Research
Griffon (GFF) intends to offer 8 million common shares to the public in an underwritten offer. The funds raised will be used for debt reduction and other corporate purposes.
Carlisle's (CSL) Board Okays 5% Hike in Quarterly Dividend
by Zacks Equity Research
Carlisle (CSL) rewards shareholders with a 5% hike in the quarterly dividend rate. This underpins its strong cash position.
The Market Timing Secrets No One Talks About - July 23, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Carlisle (CSL) Q2 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
Carlisle's (CSL) Q2 revenues decline 22.1% year over year, owing to lackluster performance across all of its segments on a decline in sales volume due to the coronavirus outbreak-led issues.
Carlisle (CSL) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Carlisle (CSL) delivered earnings and revenue surprises of 51.89% and 2.63%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Will Danaher (DHR) Keep Its Earnings Streak Alive in Q2?
by Zacks Equity Research
Danaher's (DHR) Q2 results are anticipated to reflect healthy demand for some of its products and synergistic gains from Cytiva. Yet, subdued demand for a few other products is expected to have ailed.
Why Earnings Season Could Be Great for Carlisle Companies (CSL)
by Zacks Equity Research
Carlisle Companies (CSL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Analysts Estimate Carlisle (CSL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Carlisle (CSL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Reasons Why You Should Avoid Betting on Carlisle (CSL) Now
by Zacks Equity Research
Carlisle (CSL) has been suffering from a soft demand environment amid the coronavirus outbreak. Also, the company's high debt level remains concerning.
When Does Market Timing Actually Work? - July 02, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Griffon to Pay Down Debts From Proceeds of Notes Offering
by Zacks Equity Research
Griffon (GFF) closes the offering of $150 million worth of senior notes. The proceeds will be used for redeeming notes due to expire in 2022, and pay for fees and expenses.
3M's (MMM) Sales Fall Y/Y in May on Lower Business Days
by Zacks Equity Research
3M's (MMM) weak sales performance in May gets affected by two lower business days. Also, the pandemic-induced uncertainties play spoilsport for segments and end-market businesses.
Yes, You Can Time the Market. Find out How - June 10, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Griffon (GFF) Prices $150M Worth of Senior Notes Offering
by Zacks Equity Research
Griffon (GFF) prices $150 million worth of senior notes offering. The proceeds will likely be used for redeeming notes due to expire in 2022, and pay for fees and expenses.
Carlisle (CSL) Declines 19.6% YTD: What's Hurting the Stock?
by Zacks Equity Research
Carlisle (CSL) has been suffering from weak end markets on account of the coronavirus outbreak-led uncertainties, high debt level and other issues.
3M's (MMM) Solid Product Portfolio to Aid Amid Pandemic
by Zacks Equity Research
3M (MMM) faces risks from the pandemic-related uncertainties, evident from a sales decline in April. However, cost-reduction measures and huge demand for respirators will likely support results in the second quarter.
Crane's (CR) Prospects Bleak on Pandemic-Related Concerns
by Zacks Equity Research
Crane's (CR) first-quarter performance suffers from pandemic woes, which are also expected to hurt results in the quarters ahead. Forex woes and the ability to repay debts are other concerns.